CSL Stock Forecast, Price & News

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CSL in the last year. There are currently 6 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CSL stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CSLLY, but not buy additional shares or sell existing shares.
View analyst ratings for CSL or view top-rated stocks.

Wall Street analysts have given CSL a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but CSL wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

CSL saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 8,400 shares, a decrease of 80.4% from the August 15th total of 42,900 shares. Based on an average daily trading volume, of 74,200 shares, the days-to-cover ratio is currently 0.1 days.
View CSL's Short Interest.

CSL's stock was trading at $101.09 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CSLLY shares have increased by 11.1% and is now trading at $112.34.
View which stocks have been most impacted by COVID-19.

CSL declared a Semi-Annual dividend on Thursday, February 18th. Stockholders of record on Thursday, March 4th will be given a dividend of $0.47 per share on Monday, April 12th. The ex-dividend date is Wednesday, March 3rd. This is an increase from CSL's previous Semi-Annual dividend of $0.45.
View CSL's dividend history.

CSL pays an annual dividend of $1.08 per share and currently has a dividend yield of 0.96%. The dividend payout ratio of CSL is 41.38%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CSL will have a dividend payout ratio of 36.99% next year. This indicates that CSL will be able to sustain or increase its dividend.
View CSL's dividend history.

Some companies that are related to CSL include Roche (RHHBY), Pfizer (PFE), Novo Nordisk A/S (NVO), Abbott Laboratories (ABT), Eli Lilly and (LLY), AbbVie (ABBV), Novartis (NVS), Merck & Co., Inc. (MRK), AstraZeneca (AZN), Bristol-Myers Squibb (BMY), Sanofi (SNY), GlaxoSmithKline (GSK), Zoetis (ZTS), Regeneron Pharmaceuticals (REGN) and Takeda Pharmaceutical (TAK).
View all of CSLLY's competitors.

CSL trades on the OTCMKTS under the ticker symbol "CSLLY."

Shares of CSLLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CSLLY stock can currently be purchased for approximately $112.34.

CSL has a market capitalization of $102.38 billion and generates $10.31 billion in revenue each year. The company earns $2.38 billion in net income (profit) each year or $2.61 on an earnings per share basis.

CSL employs 25,000 workers across the globe.

CSL was founded in 1904.

The official website for CSL is www.csl.com.au.

CSL is headquartered at 45 Poplar Road, Parkville C3, 3052.

CSL's mailing address is 45 Poplar Road, Parkville C3, 3052. The company can be reached via phone at (139) 389-1911 or via email at [email protected].